Skip to main content
. 2024 Mar 11;116(6):957–965. doi: 10.1093/jnci/djae060

Table 6.

Number of frameshift mutations detected in cell-free DNA from high microsatellite instability patients

Sample ID Variants, No. Targets, No. Cell-free DNA yield, ng
Heidelberg
P1a 4 4 6.10
P2a 2 2 3.67
P3a 1 1 9.16
P4a 23 21 12.07
P5 105 81 10.84
P6 9 9 5.91
P7a 3 3 4.90
P8 2 2 6.16
P9a 1 1 4.76
P10a 2 2 4.96
P11 3 3 2.22
P12 7 6 1.74
P13 7 7 2.29
P14 8 8 1
P15 47 45 1.65
P16 104 79 10.25
P17a 3 3 < 1
Weill Cornell
P20-1b 2 2 11.33
P20-2b 11 10 10.63
P21 4 4 64.9
P22 11 10 177.1
P23 18 17 56.1
Tissue For Research Ltd
P50 72 61 12.43
P51 61 56 4.71
P52 6 6 7.74
P53a 14 14 2.51
P54a 8 8 4.68
P55c 9 9 444
P56c 6 6 21.45
P57c 3 3 552
P61 5 5 2.18
P62c 53 50 22.95
Colon Cancer Family Registry
P30 10 9 1.49
P31 10 10 3.67
P34 9 9 4.4
P35 2 2 1.87
P36 4 4 21.89
P37 4 4 36.41
a

Failed quality control due to low unique DNA start sites per gene-specific primer 2 (<50).

b

A Lynch syndrome carrier without active tumor detected at the blood collection time points.

c

Serum was used in the analysis. All the remaining cell-free DNA were from plasma.